TAMARA A. FAVORITO - 30 Aug 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Director
Signature
/s/ Tamara A. Favorito
Issuer symbol
KTRA
Transactions as of
30 Aug 2023
Net transactions value
$0
Form type
4
Filing time
01 Sep 2023, 19:00:38 UTC
Previous filing
08 Aug 2023
Next filing
01 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +8,500 $0.000000 8,500 30 Aug 2023 Common Stock 8,500 $4.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on September 30, 2023.